# clm_426EFFDCB275

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 24,904,400,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2023-12-31  
published: 2023-11-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_FF328F070B8B  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 24,904,400,000 United States dollar", as of 2023-09-30 (until 2023-12-31). Claim clm_426EFFDCB275, https://asof.is/claim/clm_426EFFDCB275, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-11-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-11-02)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 24,017,900,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_426EFFDCB275](/claim/clm_426EFFDCB275.md) | [clm_C2064E6D19CF](/claim/clm_C2064E6D19CF.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.